FRI0331 Apremilast for the treatment of behçet's syndrome: a phase ii randomized, placebo-controlled, double-blind studyGülen Hatemi, Yusuf Yazıcı, Recep Tunç et al.|Annals of the Rheumatic Diseases|2013Cited by 8